Form 4 for TXMD TherapeuticsMD, Inc.
Accepted 2022-08-22 00:00:00 ET · period of report 2022-08-18 · accession 0001209191-22-046963 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-08-22 | 2022-08-18 | TXMD | BISARO PAUL | Dir | M - OptEx | — | +1,984 | 5,922 | +50% | — |
| D | 2022-08-22 | 2022-08-18 | TXMD | BISARO PAUL | Dir | M - OptEx | $0.00 | -1,984 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-08-18 | M | A | 1,984 | — | 5,922 | D | — | — | (F1) On August 18, 2022, the reporting person received 1,984 shares of common stock of the issuer in settlement of restricted stock units (RSUs), which vested on July 1, 2022. |
| 2 | Derivative | Restricted Stock Units | 2022-08-18 | M | D | 1,984 | $0.00 | 0 | D | $0.00 · — to — | 1,984 Common Stock | (F2) Each RSU represents a contingent right to receive one share of issuer common stock upon settlement. (F1) On August 18, 2022, the reporting person received 1,984 shares of common stock of the issuer in settlement of restricted stock units (RSUs), which vested on July 1, 2022. (F3) The RSUs vested on July 1, 2022. |